Healthcare & Medical Devices Global On demand · 24-48h

Global Vapor Phase Liquid Nitrogen Storage System Market Strategic Research Report

Global Vapor Phase Liquid Nitrogen Storage System Market Str…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Vapor Phase Liquid Nitrogen Storage System Market
$1582025
7.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Manual Vapor-Phase LN2 Storage Systems, Auto-Fill Vapor-Phase LN2 Storage Systems, Isothermal Dry-Vapor LN2 Storage Systems, Automated Robotic Vapor-Phase Cryostorage Systems, Vapor-Phase Dry Shippers

By Application: Biobanks and Biorepositories, Cell Therapy and Biomanufacturing, Assisted Reproduction, Clinical Sample Storage, Research and Academic Laboratories, Animal Germplasm and Agriculture

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, MVE Biological Solutions, Azenta Life Sciences, Haier Biomedical, IC Biomedical, Custom Biogenic Systems, PHCbi, Cryotherm, Statebourne Cryogenics, Planer, Genepoint Technologies, Mether Biomedical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 116 pages
Market size 2025
$158
Million USD
Forecast CAGR
7.3%
2025-2032
Forecast 2032
$258.7
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Vapor Phase Liquid Nitrogen Storage System market size is predicted to grow from US$ 158 million in 2025 to US$ 258 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

A vapor phase liquid nitrogen storage system stores samples in the nitrogen vapor zone above the liquid nitrogen level. It combines a vacuum-insulated vessel, inventory racks, level and temperature control, alarms, and data logging to support long-term cryogenic preservation of cells, tissues, blood, sperm, oocytes, vaccines, and other biological samples. Compared with liquid-phase immersion, vapor-phase storage reduces the risk of liquid entering cryotubes, tube rupture, and cross-contamination while maintaining a stable environment close to liquid nitrogen temperature. It is used in biobanks, cell therapy, assisted reproduction, clinical laboratories, and research institutions. Product value is mainly determined by insulation performance, temperature uniformity, LN2 consumption, auto-fill control, monitoring traceability, storage density, and validation service capability, with an overall gross margin of about 45%.

Demand is driven by biobank expansion, industrialization of cell and gene therapy, long-term sample preservation in assisted reproduction centers, hospital research platforms, and vaccine or biologics sample management. Buyers are moving from basic cold storage toward sample safety, traceability, and continuous operation, so vapor-phase storage is increasingly favored for high-value samples because it reduces direct liquid nitrogen contact and contamination risk.

Product upgrades focus on auto-fill control, dual temperature and level monitoring, remote alarms, audit trails, low evaporation vessels, and high-density inventory racks. Traditional manual LN2 containers still serve laboratories and smaller institutions, while automated vapor-phase systems and robotic picking platforms are aimed at large biorepositories, cell therapy manufacturers, and high-throughput clinical sample management. Leading suppliers have stronger positions in vacuum insulation, controllers, sample management software, and service networks, while domestic manufacturers are improving quickly in cost, delivery, and localized system integration.

North America and Europe emphasize compliance, validation documentation, and long-term service, while Asian demand is supported by hospital biobanks, research infrastructure, and cell therapy investment. Key risks include LN2 supply security, oxygen monitoring and ventilation requirements, liability for sample loss caused by equipment failure, and partial substitution by mechanical cryogenic freezers or automated cold-storage platforms. Suppliers with integrated equipment, consumables, software, and maintenance capabilities are better positioned to enter large institutional accounts.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vapor Phase Liquid Nitrogen Storage System market?

What factors are driving Vapor Phase Liquid Nitrogen Storage System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vapor Phase Liquid Nitrogen Storage System market opportunities vary by end market size?

How does Vapor Phase Liquid Nitrogen Storage System break out by Type, by Application?

This report presents a comprehensive overview of the global Vapor Phase Liquid Nitrogen Storage System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Manual Vapor-Phase LN2 Storage Systems
  • Auto-Fill Vapor-Phase LN2 Storage Systems
  • Isothermal Dry-Vapor LN2 Storage Systems
  • Automated Robotic Vapor-Phase Cryostorage Systems
  • Vapor-Phase Dry Shippers

Segment by Sample Capacity

  • Small-Capacity Systems
  • Medium-Capacity Systems
  • Large-Capacity Systems
  • Ultra-Large Biobank Systems

Segment by Temperature Control and Monitoring

  • Basic Manual Monitoring Systems
  • Automatic Fill and Level Control Systems
  • Temperature and Alarm Data-Logging Systems
  • Networked Remote Monitoring Systems
  • GMP Traceable Management Systems

Segment by LN2 Supply and Deployment

  • Stand-Alone Manual-Fill Systems
  • Stand-Alone Auto-Fill Systems
  • Central LN2 Pipeline Systems
  • Modular Freezer Farm Systems
  • Mobile and Transport Systems

Segment by Application

  • Biobanks and Biorepositories
  • Cell Therapy and Biomanufacturing
  • Assisted Reproduction
  • Clinical Sample Storage
  • Research and Academic Laboratories
  • Animal Germplasm and Agriculture

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Vapor Phase Liquid Nitrogen Storage System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biobanks and Biorepositories, Cell Therapy and Biomanufacturing, Assisted Reproduction evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Vapor Phase Liquid Nitrogen Storage System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$158
2025
Forecast
$258.7
2032
CAGR
7.3%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificMVE Biological SolutionsAzenta Life SciencesHaier BiomedicalIC BiomedicalCustom Biogenic SystemsPHCbiCryotherm
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Manual Vapor-Phase LN2 Storage SystemsAuto-Fill Vapor-Phase LN2 Storage SystemsIsothermal Dry-Vapor LN2 Storage SystemsAutomated Robotic Vapor-Phase Cryostorage SystemsVapor-Phase Dry Shippers
By Application
Biobanks and BiorepositoriesCell Therapy and BiomanufacturingAssisted ReproductionClinical Sample StorageResearch and Academic LaboratoriesAnimal Germplasm and Agriculture

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Manual Vapor-Phase LN2 Storage Systems
  • 3.1.3 Auto-Fill Vapor-Phase LN2 Storage Systems
  • 3.1.4 Isothermal Dry-Vapor LN2 Storage Systems
  • 3.1.5 Automated Robotic Vapor-Phase Cryostorage Systems
  • 3.1.6 Vapor-Phase Dry Shippers
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biobanks and Biorepositories
  • 4.1.3 Cell Therapy and Biomanufacturing
  • 4.1.4 Assisted Reproduction
  • 4.1.5 Clinical Sample Storage
  • 4.1.6 Research and Academic Laboratories
  • 4.1.7 Animal Germplasm and Agriculture
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 MVE Biological Solutions
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Azenta Life Sciences
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Haier Biomedical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 IC Biomedical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Custom Biogenic Systems
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 PHCbi
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Cryotherm
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Statebourne Cryogenics
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Planer
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Genepoint Technologies
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Mether Biomedical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Vapor Phase Liquid Nitrogen Storage System market size?
The global Vapor Phase Liquid Nitrogen Storage System market is estimated at US$ 158 million in 2025 (base year) and is projected to reach US$ 258 million by 2032.
What growth rate is expected for the Vapor Phase Liquid Nitrogen Storage System market through 2032?
The market is expected to grow at a CAGR of 7.3% from 2026 to 2032, expanding from US$ 158 million in 2025 to US$ 258 million in 2032, roughly 1.6 times its base-year value.
How is Vapor Phase Liquid Nitrogen Storage System defined?
A vapor phase liquid nitrogen storage system stores samples in the nitrogen vapor zone above the liquid nitrogen level. It combines a vacuum-insulated vessel, inventory racks, level and temperature control, alarms, and data logging to support long-term cryogenic preservation of cells, tissues, blood, sperm, oocytes, vaccines, and other biological samples.
How is the Vapor Phase Liquid Nitrogen Storage System market segmented by type?
By type, the market is segmented into Manual Vapor-Phase LN2 Storage Systems, Auto-Fill Vapor-Phase LN2 Storage Systems, Isothermal Dry-Vapor LN2 Storage Systems, Automated Robotic Vapor-Phase Cryostorage Systems and Vapor-Phase Dry Shippers.
What are the key applications of Vapor Phase Liquid Nitrogen Storage System?
Key applications covered include Biobanks and Biorepositories, Cell Therapy and Biomanufacturing, Assisted Reproduction, Clinical Sample Storage, Research and Academic Laboratories and Animal Germplasm and Agriculture.
Which companies are profiled in the Vapor Phase Liquid Nitrogen Storage System market report?
Key players profiled include Thermo Fisher Scientific, MVE Biological Solutions, Azenta Life Sciences, Haier Biomedical, IC Biomedical, Custom Biogenic Systems, PHCbi and Cryotherm, among 12 companies covered in total.
What geographies does the Vapor Phase Liquid Nitrogen Storage System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Vapor Phase Liquid Nitrogen Storage System?
Demand is driven by biobank expansion, industrialization of cell and gene therapy, long-term sample preservation in assisted reproduction centers, hospital research platforms, and vaccine or biologics sample management.
Who should buy the Vapor Phase Liquid Nitrogen Storage System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biobanks and Biorepositories, Cell Therapy and Biomanufacturing and Assisted Reproduction, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Vapor Phase Liquid Nitrogen Storage System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.